Waters Corp.'s $17.5B merger with BD Biosciences aims to double revenue but raises risks. Read here for an investment ...

President Trump is pushing through with his tariff agenda, unveiling a new batch of letters to country leaders outlining ...

This stock used to be a highflyer but has struggled in recent years as demand waned for its flagship product. Though Moderna ...

Deo circles back to the common theme at AWS. “Speed is our advantage,” he says, echoing AWS Chief Executive Matt Garman’s mantra. “We have to deliver hardware, cost controls, guardrails and creativity ...

Lab equipment maker Waters Corp on Monday said it will buy a bioscience and diagnostics unit spun off from medtech provider ...

A pharmaceutical company is closing its Wilmington manufacturing facility this year and plans to lay off 75 people who work ...

A subtle ad about breast cancer self-checks led me to reflect on my own experience and the complex role of pharmaceutical companies in awareness.

Baxdrostat, which AstraZeneca acquired in a 2023 buyout of CinCor Pharma, could become a new treatment for people whose hypertension is either uncontrolled by or resistant to existing medicines.

The CDMO, which has been owned by different private investors over the last decade, will use the funds to broaden its geographic reach.

President Trump is pushing through with his tariff agenda, unveiling a new batch of letters to country leaders outlining ...

Rocket Lab is making serious headlines as its stock soars over 8%, driven by big moves like its Neutron rocket launch plan ...

Bristol Myers Squibb has opened its radiopharmaceutical manufacturing facility in Indianapolis, which played a major role in ...